Authors: Musoke, P Guay, LA Bagenda, D Mirochnick, M Nakabiito, C Fleming, T Elliott, T Horton, S Dransfield, K Pav, JW Murarka, A Allen, M Fowler, MG Mofenson, L Hom, D Mmiro, F Jackson, JB

Citation: P. Musoke et al., A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006), AIDS, 13(4), 1999, pp. 479-486

Authors: Guay, LA Musoke, P Fleming, T Bagenda, D Allen, M Nakabiito, C Sherman, J Bakaki, P Ducar, C Deseyve, M Emel, L Mirochnick, M Fowler, MG Mofenson, L Miotti, P Dransfield, K Bray, D Mmiro, F Jackson, JB

Citation: La. Guay et al., Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVMET 012 randomised trial, LANCET, 354(9181), 1999, pp. 795-802

Authors: Pollard, RB Robinson, P Dransfield, K

Citation: Rb. Pollard et al., Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection, CLIN THER, 20(6), 1998, pp. 1071-1092